JAMA study questions FDA's shorter drug approval times

By Toni Clarke WASHINGTON (Reuters) - New drugs that receive expedited review by the Food and Drug Administration are being tested on fewer patients, leaving many safety questions unanswered even after they are approved, a study released on Monday in the Journal of the American Medical Association found. Study authors Thomas Moore of the Institute for Safe Medication Practices and Dr Curt Furberg, a professor at Wake Forest School of Medicine, examined the development times, clinical testing and risks associated with 20 new drugs approved in 2008. ...



via Health News Headlines - Yahoo! News http://news.yahoo.com/jama-study-questions-fdas-shorter-drug-approval-times-222351801.html